Colchicine for people on dialysis
Treatments studied
Part of Kidney & urinary clinical trials.
This study tests whether the medicine colchicine, which reduces inflammation, can be safely given to people having haemodialysis. It aims to see if it's possible to run a larger trial in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having haemodialysis treatment for kidney failure.
- You are 18 years old or older.
- You can understand and agree to take part in the study.
- You are not already taking colchicine for another condition.
- You do not have a known allergy or intolerance to colchicine.
- You do not have chronic liver disease or abnormal liver function tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
This study tests whether a daily low dose of colchicine, a medicine used for gout and inflammation, can reduce inflammation and improve blood vessel and bone health in people with chronic kidney disease. It might help prevent complications like heart disease and weak bones.
This Phase 2 trial tests whether colchicine can reduce inflammation and improve heart function in people with kidney disease and a certain type of heart problem. If you qualify, you’ll be closely monitored for side effects and lab changes.
This study tests whether taking a daily low dose of colchicine, a medicine used for inflammation, can help prevent a first heart attack or other heart problems in people who are at higher risk due to their risk factors. If you qualify, you would be assigned to take either colchicine or a placebo (a pill with no active medicine) to see if it helps keep your heart healthy.
This trial tests if the anti-inflammatory drug colchicine can help people hospitalized with acute heart failure and a weak heart pump. It may benefit those with elevated inflammation markers.
Hear when a new Haemodialysis Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.